New York – Page 48

Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More

This week started with celebrations of America’s birthday, and it has been dominated—biotech-wise—by America’s government. The Obama administration continued its high-profile involvement in the life sciences by updating its Precision Medicine Initiative, easing limits on doctors who want to fight opioid addiction, and stopping a clinical trial in one of the hottest biomedical fields, cancer … Continue reading “Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More”

Recombine Obtains $8,438,335 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c5df15c-cee6-4f36-bc61-d8e686291700 Date 7/8/2016 Company Name Recombine Mailing Address 1140 Broadway New York, NY 10001 USA Company Description Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine’s genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers. Website http://www.recombine.com Transaction Type Venture Equity … Continue reading “Recombine Obtains $8,438,335 New Round”

Mark43 Garners $26,999,950 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b885373b-e19f-40f9-b145-e9fcc9b844f0 Date 7/8/2016 Company Name Mark43 Mailing Address 27 W 24th St. 5th Floor New York, NY 10010 USA Company Description Mark43 – it’s the 21st century and the next generation of policing software is finally here. Website http://www.mark43.com Transaction Type Venture Equity Transaction Amount $26,999,950 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “Mark43 Garners $26,999,950 New Funding Round”

Pairaphrase Pushes Smart, Secure Language Translation Software

A Royal Oak, MI-based startup focused on language translation software is heading to New York City this fall to compete in Techweek’s Launch competition. Pairaphrase was founded by Rick Woyde because he thought he could offer a better, more private alternative to Google Translate. Woyde is the longtime owner of Language Arts & Science, a … Continue reading “Pairaphrase Pushes Smart, Secure Language Translation Software”

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. Morristown, NJ-based Pernix (NASDAQ: [[ticker:PTX]]) will cut 60 workers, mostly from its neurology sales staff, the company said today. As of the end of 2015, Pernix reported a headcount … Continue reading “Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy”

KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash

KaloBios Pharmaceuticals has signed an agreement with its former CEO, the embattled drug executive Martin Shkreli, to potentially buy back remaining stock Shkreli owns and to restrict his ability to sell his shares to others. The news comes a week after KaloBios—the Brisbane, CA-based biotech that was acquired by Shkreli shortly before his arrest on … Continue reading “KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash”

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today. National Institutes of Health director Francis Collins (pictured) and FDA commissioner Rob Califf spoke on a call this afternoon to update the Precision Medicine Initiative, … Continue reading “Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years”

Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition

Rare disease drug developer Amicus Therapeutics has added a new prospect to its pipeline with the acquisition of a biologic program that the company hopes will eventually treat a genetic disorder whose seizures and neurological impairments have no approved treatment or cure. That preclinical program comes from MiaMed, a company that Amicus (NASDAQ: [[ticker:FOLD]]) said … Continue reading “Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition”

Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

Bind Therapeutics and its treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May, asked the bankruptcy court on July 1 to approve a stalking-horse bid from Pfizer for $20 million, a fraction of the $70.5 million it raised in an initial … Continue reading “Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M”

IBM Opens Bluemix Garage in NY for Devs Working on Blockchain Tech

A new workshop opened last week in New York where developers can fine- tune their blockchain software. IBM has set up a Bluemix Garage in SoHo within a Galvanize campus that also just opened in town. The “garage” is a place where local developers, from startups and enterprises alike, can collaborate with tech experts and use … Continue reading “IBM Opens Bluemix Garage in NY for Devs Working on Blockchain Tech”

Payfone Lands $2,660,723 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=228da06b-cd7f-4b59-b5ca-9bcd8132c1c2 Date 7/6/2016 Company Name Payfone Mailing Address 215 Park Avenue South 11th Floor New York , NY 10003 USA Company Description Payfone, Inc. allows users to pay for online goods and services using mobile credit. Website http://www.payfone.com Transaction Type Venture Equity Transaction Amount $2,660,723 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “Payfone Lands $2,660,723 New Funding”

Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal

Bristol-Myers Squibb has acquired cancer and rare disease drug developer Cormorant Pharmaceuticals, a deal that includes an early-stage cancer compound that could complement the way Bristol’s own immune-oncology treatments work. New York-based Bristol (NYSE: [[ticker:BMY]]) said Tuesday that it has acquired all of the outstanding stock of privately held Cormorant for $95 million in up … Continue reading “Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal”

3 Things You (Probably) Don’t Know about Indiana Innovation

People who live outside of Indiana probably know a few things about it: The Indianapolis 500, a.k.a. “The Greatest Spectacle in Racing,” is run every Memorial Day weekend; Indiana limestone was used to build the Empire State Building, the National Cathedral, and the Pentagon; and Indiana sugar cream pie is the best dessert ever. But … Continue reading “3 Things You (Probably) Don’t Know about Indiana Innovation”

Xconomy’s Top Innovation Stories of the Half Year

Here we are at the midpoint of 2016 already. Time to look back on the past six months—and some of the top stories of the year so far. The following represent a cross-section of what Xconomy offers on a daily basis: in-depth reporting from the front lines of technology and business innovation; coverage from 11 … Continue reading “Xconomy’s Top Innovation Stories of the Half Year”

Milestones of Innovation 12: Overflight Of Russia’s Ultimate Weapons

Sixty years ago, on the Fourth of July, 1956, the American President gained a capacity that has never been lost: clear pictures from above of Russia’s thermonuclear weapons delivery system. Because the images ended up shrinking the world’s appetite for tools of ultimate destruction, it is hard to think of a more significant innovation. The … Continue reading “Milestones of Innovation 12: Overflight Of Russia’s Ultimate Weapons”

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

The word of the week was “moonshot,” as U.S. Vice President Joe Biden’s cancer initiative convened a summit in Washington, DC. At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences … Continue reading “Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More”

Why Finance Should Take a Page Out of the Credit Card Industry’s Book

U.S. federal and financial regulators recently advised banks nationwide to assess the strength of their safeguards against cyber fraud. The warning comes after a string of cyber heists and attempted heists against banks around the world, including the $81 million theft from the Bangladesh central bank. These crimes have opened the financial industry’s eyes to … Continue reading “Why Finance Should Take a Page Out of the Credit Card Industry’s Book”

dv01 Receives $7,500,000 Seed Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f4cf0ed6-7225-47c6-bb01-8afbcc3a30cb Date 7/1/2016 Company Name dv01 Mailing Address 915 Broadway New York, NY 10010 USA Company Description dv01 brings transparency to lending markets. The analytics and reporting platform increases liquidity by simplifying all aspects of loan and bond investment, from portfolio management to securitization. Website http://www.dv01.co Transaction Type Venture Equity Transaction Amount … Continue reading “dv01 Receives $7,500,000 Seed Financing”

Kontakt.io Obtains $500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=11002cfe-01f7-4d4c-b44d-bb72431b9307 Date 7/1/2016 Company Name Kontakt.io Mailing Address 99 Hudson St. 5th Floor New York, NY 10013 USA Company Description Kontakt.io was founded in 2013 with the goal of helping the visually impaired navigate public spaces more easily, and experience cultural wonders with the same appreciation as anyone else. Website http://www.kontakt.io Transaction … Continue reading “Kontakt.io Obtains $500,000 New Round”

Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End?

As part of a national cancer “moonshot” initiative led by Vice President Joe Biden, the FDA said Wednesday it would retool the way it evaluates cancer treatments and tests. But to what end? The goals of the FDA’s new Oncology Center of Excellence remain vague, as does its structure. In a speech Wednesday morning at … Continue reading “Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End?”

Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup

Inside our bodies, our cells move around, communicate, form new tissue, and heal wounds with the help of proteins called integrins. But when disease occurs, integrins get the wrong cues and do damage—they might help tumors grow, or promote inflammation or scarring inside the body. Several drugs to block bad integrin behavior and treat a … Continue reading “Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup”

No Stairway (Infringement) and the Importance of Shared Design Tools in Innovation

Led Zeppelin just won a major copyright case defending against infringement claims from the estate of Randy California—songwriter for the band Spirit. At first listen, the opening guitar part of Zeppelin’s Stairway to Heaven does sound a lot like California’s guitar part in the middle of Taurus. But as I explain in a longer blog … Continue reading “No Stairway (Infringement) and the Importance of Shared Design Tools in Innovation”

With $18M, Reflexion Health Expands Physical Therapy Technology

Reflexion Health, a San Diego startup founded in 2012 at the nonprofit West Health Institute, is moving to commercialize Vera, its physical rehabilitation system based on Microsoft Kinect’s motion tracking technology. After recently raising $18 million in Series B funding, the healthtech company also plans to add new products as it expands nationally among U.S. … Continue reading “With $18M, Reflexion Health Expands Physical Therapy Technology”

Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact

Moderna Therapeutics still hasn’t produced data in humans supporting its technology, which is meant to turn our bodies into little drugmaking factories. But the Cambridge, MA-based company nonetheless keeps grabbing the attention, and cash, of other drugmakers. Moderna said today that it will work with Merck (NYSE: [[ticker:MRK]]) to develop “personalized” cancer vaccines based on … Continue reading “Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact”

Crowded.com Receives $3,300,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54bdbd51-fb9a-460f-b40e-0d492be9a7b2 Date 6/29/2016 Company Name Crowded.com Mailing Address 19 west 34th St. 10th Floor New York, NY 10001 USA Company Description Crowded.com is a mobile-first candidate network where hourly and on-demand workers “Get Verified and Get Hired”. Workers maintain their Crowded.com profile, get verified, engage in training and assessments, explore potential career … Continue reading “Crowded.com Receives $3,300,000 Seed Round”

Progyny Secures $14,700,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fed9eb66-3827-412b-8c0c-dbd77051be14 Date 6/29/2016 Company Name Progyny Mailing Address 99 Hudson Street 7th Floor New York, NY 10013 USA Company Description Progyny is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions. We are committed … Continue reading “Progyny Secures $14,700,000 Series B Round”

PredictSpring Secures $11,400,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8eadb81-9af1-4994-a265-e1a36a20025e Date 6/29/2016 Company Name PredictSpring Mailing Address Undisclosed New York, NY 10011 USA Company Description PredictSpring is revolutionizing mobile commerce with an innovative technology platform that dramatically improves and simplifies the way consumers shop on mobile phones. Website http://www.predictspring.com Transaction Type Venture Equity Transaction Amount $11,400,000 Transaction Round Series A Proceeds … Continue reading “PredictSpring Secures $11,400,000 Series A Funding Round”

Bizfi Lands $20,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=af4cbc82-cd6b-44dc-a302-eeac60280f76 Date 6/29/2016 Company Name Bizfi Mailing Address 460 Park Avenue South 10th Floor New York, NY 10016 USA Company Description Bizfi delivers business finance solutions in real time, helping small businesses grow by providing a variety of loan options through our funding platform. Website http://www.bizfi.com Transaction Type Venture Equity Transaction Amount … Continue reading “Bizfi Lands $20,000,000 New Funding”

Flip Obtains $1,200,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f07440cf-8660-4959-9cf7-dc6b95d9f184 Date 6/29/2016 Company Name Flip Mailing Address 69 Charlton St. New York, NY 10014 USA Company Description Flip is a way for people to buy and sell leases from each other. If you have 4 months, or 4 years, left on a lease but you want to move – put a … Continue reading “Flip Obtains $1,200,000 Seed Round”

Startup M&A: Why a Letter of Intent Deserves Your Full Attention

You might know it as a letter of intent or a term sheet. Maybe you’ve heard it referred to as an MOU, or memorandum of understanding. Whatever you call it, this document of about five pages is a summary of the terms of a deal the parties hope to close down the line. If buyers … Continue reading “Startup M&A: Why a Letter of Intent Deserves Your Full Attention”

Modern Meadow Collects $40M for Real Leather With ‘No Cow Involved’

Modern Meadow, a New York-based company that has developed a method of turning living cells into materials used to make leather that mimics animal hide, has received a $40 million Series B funding to begin manufacturing and commercializing its leather products. The company has developed a line of cells that produce collagen, a protein that … Continue reading “Modern Meadow Collects $40M for Real Leather With ‘No Cow Involved’”

Can the Digital World Change the Wine and Spirits Industry?

Every day it seems a new tech startup emerges to tap the keg of the spirits industry, especially on the consumer delivery side. The team at New York’s SevenFifty took on a different approach, however, trying to fix inefficiencies in the alcohol distribution cycle. A recent funding round is giving SevenFifty fuel to grow. The … Continue reading “Can the Digital World Change the Wine and Spirits Industry?”

Modern Meadow Lands $40,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=095ebe38-4cfa-4702-82d5-7ed4ba5cb141 Date 6/28/2016 Company Name Modern Meadow Mailing Address 140 58th Street Brooklyn, NY 11220 USA Company Description More than ever, global population growth and rising consumption levels are stretching the world’s resources. For materials as fundamental as meat and leather, our planet’s capacity is being stretched to the limit. Website http://www.modernmeadow.com … Continue reading “Modern Meadow Lands $40,000,000 Series B Financing Round”

Brexit and the Impact in the London Startup Industry

Editor’s note: Xconomy invited Marcelo Calbucci, a Seattle serial entrepreneur and startup stalwart who just announced plans to move with his family to London, to reflect on the Brexit vote. No, the skies are not falling. The U.K. vote to exit the European Union has passed, and there is an enormous amount of uncertainty right … Continue reading “Brexit and the Impact in the London Startup Industry”

Splash Secures $2,500,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=493e52e9-8731-438c-9140-84beec17e54e Date 6/27/2016 Company Name Splash Mailing Address 122 W 26th St. 4th Floor New York, NY 10001 USA Company Description Splash is the comprehensive events management platform that maximizes event impact – before, during, and after. Share the action as it happens, with real-time social integration and curation. Website http://www.splashthat.com Transaction … Continue reading “Splash Secures $2,500,000 New Funding Round”

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’ historic comeback that brought the city its first sports title in over 50 years. … Continue reading “Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More”

Colu Garners $9,600,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43a720f4-3a2c-40da-9e91-018346a45252 Date 6/24/2016 Company Name Colu Mailing Address 636 Avenue of the Americas 6th Floor New York, NY 10010 USA Company Description CoinDesk is the world leader in news and information on digital currencies such as bitcoin, and its underlying technology – the blockchain. Website http://www.coindesk.com Transaction Type Venture Equity Transaction Amount … Continue reading “Colu Garners $9,600,000 New Financing Round”

Twilio’s $150M IPO May Bolster Faith In Unicorns—-Or Some Of Them

Venture investors, as well as tech companies hesitant to try going public, were hanging on the outcome of communications software company Twilio’s IPO this week in hopes that it would signal a thaw in the mood on Wall Street for such offerings. So far, Twilio is delivering a strong positive signal. The San Francisco-based company … Continue reading “Twilio’s $150M IPO May Bolster Faith In Unicorns—-Or Some Of Them”

The Evolution of the App Stores

In many ways, Apple and Google are following similar paths. At their annual developer conferences, Google I/O, held last month, and Apple’s WWDC, last week they both announced updates to their development platforms. Google is making major improvements to Android Studio, while Apple is continuing to invest in Swift and announced Playgrounds, an exciting new … Continue reading “The Evolution of the App Stores”

SecurityScorecard Secures $20,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=98375940-dedb-4884-b7e4-59afe7e10ab2 Date 6/23/2016 Company Name SecurityScorecard Mailing Address 22 W 19th St. 9th Floor New York, NY 10011 USA Company Description Work with, not against, your partners to effectively remediate immediate threats and lower collective security risks through alerts, validation and workflow ticketing. Website http://www.securityscorecard.com Transaction Type Venture Equity Transaction Amount $20,000,000 … Continue reading “SecurityScorecard Secures $20,000,000 Series B Funding”

Common Garners $1,700,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a339af2a-693d-42e9-963a-96ad94adfdd8 Date 6/23/2016 Company Name Common Mailing Address Undisclosed Brooklyn, NY 11217 USA Company Description Common offers flexible, community-driven housing by providing fully furnished, month-to-month memberships, beginning in New York City. Website http://www.hicommon.com Transaction Type Debt Transaction Amount $1,700,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 5 investors participated … Continue reading “Common Garners $1,700,000 New Round”

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it’s more about action. The healthcare computing giant, now headquartered in Cambridge, MA, is unveiling a collaborative effort in medical imaging that includes partnerships with health systems, radiology providers, tech companies, and academic medical centers. Watson Health is pushing … Continue reading “IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases”

Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case

Because public investors have had a more discerning attitude toward biotech IPOs this year, insiders have had to step up to help their companies go public. One extreme example is Selecta Biosciences, which just priced its offering late Tuesday with its pre-IPO investors likely buying around 60 percent of the shares. Selecta, of Watertown, MA, … Continue reading “Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case”

Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases

There is no shortage of companies out there trying to tweak our immune systems in one way or another to treat diseases like cancer. Today, IFM Therapeutics, a new startup seeded by Boston firm Atlas Venture, has joined the fray. IFM, a startup in Cambridge, MA, disclosed a $27 million Series A round led by … Continue reading “Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases”

The Muse Receives $16,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b8e42da-c844-4c12-bf0d-d13931e3e353 Date 6/22/2016 Company Name The Muse Mailing Address 151 West 25th Street 9th Floor New York, NY 10001 USA Company Description The Muse is a rapidly growing community of inspired professionals who believe that kicking ass and taking names is all part of the job. Whether you’re an entrepreneur, work for … Continue reading “The Muse Receives $16,000,000 Series B Financing”

Intent Media Acquires Voyat for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83e2eef5-2acc-4415-8c7f-2783c8b7725e Date 6/22/2016 Company Name Voyat Mailing Address 85 Delancey St. New York, NY 10002 USA Company Description Voyat is reinventing the way hotels interact with their guests. With our platform, hotels gain intuitive and powerful tools that drive up sales and reduce margin loss. Smart data, personalization, and predictive analytics work … Continue reading “Intent Media Acquires Voyat for Undisclosed Sum”

Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

[Updated, 6/21/16, 5:40pm. See below.] Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with a landmark clinical trial. Depending on timing, it could be the first to use the gene editing … Continue reading “Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial”

Boston Cybersecurity Firms Grab Cash, Protect Turf, Push Community

A few recent moves by Boston-area cybersecurity firms illustrate the various ways the sector’s members (and related companies) are trying to build their businesses and bolster measures to counter cyber threats: —Raising more cash: On Tuesday, Zerto said it tacked $20 million onto a $50 million growth financing round announced in January. The new investment was … Continue reading “Boston Cybersecurity Firms Grab Cash, Protect Turf, Push Community”

Mobile Real Estate Platform Developer Real Moves from Houston to NY

Things literally just got real in New York. Real, a digital mobile real estate brokerage that got its start in Houston, recently relocated its headquarters to the Flatiron District. CEO Tamir Poleg says via e-mail that the startup’s platform is aimed at independent, licensed residential real estate agents to help them manage leads and other services for … Continue reading “Mobile Real Estate Platform Developer Real Moves from Houston to NY”